Home / XBIT : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does XBIT make money? Does XBIT have pricing power? What's the Earnings Whisper? Will XBIT profit more as the business scales? What is XBIT's management track record? Is XBIT's current price justified?

XBiotech Inc.

$2.19 -$0.19 (-7.98%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$2.17

Day Range

$2.18$2.2

Year Range

$2.09$3.44

Market Cap

66.77M

AVG Volume

36.84K

Trailing/Forward PE

-1.48/-

PEG ratio

0.03

Dividend Yield

Next Earnings Date

Primary Exchange

NASDAQ

Revenue (USD) · TTM

XBIT Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0
24 Q1	0

Net Income (USD) · TTM

XBIT Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-45.13M
26 Q1	-40.16M
25 Q4	-45.54M
25 Q3	-29.16M
25 Q2	-28.16M
25 Q1	-39.41M
24 Q4	-38.53M
24 Q3	-32.66M
24 Q2	-35.01M
24 Q1	-30.74M

Operating Income (USD) · TTM

XBIT Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-48.22M
26 Q1	-48.41M
25 Q4	-55.69M
25 Q3	-34.68M
25 Q2	-36.54M
25 Q1	-45.17M
24 Q4	-42.47M
24 Q3	-42.31M
24 Q2	-42.93M
24 Q1	-41.22M

EBITDA (USD) · TTM

XBIT EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-41.77M
26 Q1	-38.33M
25 Q4	-43.53M
25 Q3	-27M
25 Q2	-25.88M
25 Q1	-37.19M
24 Q4	-36.21M
24 Q3	-30.61M
24 Q2	-32.87M
24 Q1	-28.5M

Cash Flows (USD) · TTM

XBIT Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-40.84M
26 Q1	-42.36M
25 Q4	-40.21M
25 Q3	-23.85M
25 Q2	-25.66M
25 Q1	-31.62M
24 Q4	-32.27M
24 Q3	-29.19M
24 Q2	-24.53M
24 Q1	-21.73M

EPS (USD) · TTM

XBIT EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-1.48
26 Q1	-1.32
25 Q4	-1.5
25 Q3	-0.96
25 Q2	-0.92
25 Q1	-1.29
24 Q4	-1.26
24 Q3	-1.07
24 Q2	-1.15
24 Q1	-1.01

Expenses (USD) · TTM

XBIT Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	48.36M
26 Q1	48.61M
25 Q4	55.98M
25 Q3	35.02M
25 Q2	37.1M
25 Q1	46.31M
24 Q4	43.77M
24 Q3	43.21M
24 Q2	43.52M
24 Q1	41.4M

Shares Outstanding (USD) · TTM

XBIT Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-530K
26 Q1	-465K
25 Q4	-3.62M
25 Q3	-4.09M
25 Q2	-4.43M
25 Q1	-4.7M
24 Q4	-1.75M
24 Q3	-1.81M
24 Q2	-2.4M
24 Q1	-2.94M

Dividends (USD)

XBIT Dividends (USD) by quarter
Period	Dividends (USD)
Jul 21	2.47

Employee Count

XBIT Employee Count by quarter
Period	Employee Count
2025	85
2024	92
2023	82
2022	85
2021	97
2020	91
2019	60
2018	56
2017	51
2016	106

PE Ratio

XBIT PE Ratio by quarter
Period	PE Ratio
Mar 21	0.86
Mar 21	0.8
Feb 21	0.81
Feb 21	0.85
Feb 21	0.87
Feb 21	0.86
Jan 21	0.8
Jan 21	0.72
Jan 21	0.7
Jan 21	0.75
Dec 20	0.67
Dec 20	0.72
Dec 20	0.73
Dec 20	0.81
Dec 20	0.82
Nov 20	0.83
Nov 20	0.75
Nov 20	0.84
Nov 20	0.79
Oct 20	0.73
Oct 20	0.78
Oct 20	0.82
Oct 20	0.85
Oct 20	0.78
Sep 20	0.81
Sep 20	0.91
Sep 20	0.81
Sep 20	0.78
Aug 20	0.81
Aug 20	0.79
Aug 20	0.74
Aug 20	0.81
Jul 20	0.78
Jul 20	0.82
Jul 20	0.81
Jul 20	0.79
Jul 20	0.78
Jun 20	0.78
Jun 20	0.76
Jun 20	0.71
Jun 20	0.78
May 20	0.75
May 20	0.77
May 20	0.77
May 20	0.85
May 20	0.85
Apr 20	0.74
Apr 20	0.74
Apr 20	0.72
Apr 20	0.62
Mar 20	0.53
Mar 20	0.51

Free Cash Flow Yield

XBIT Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-61.16%
Sep 26	-60.88%
Aug 26	-59.01%
Aug 26	-58.75%
Aug 26	-58.24%
Aug 26	-61.21%
Jul 26	-62.31%
Jul 26	-61.21%
Jul 26	-61.21%
Jul 26	-60.68%
Jul 26	-60.41%
Jun 26	-59.64%
Jun 26	-60.15%
Jun 26	-59.38%
Jun 26	-58.63%
May 26	-57.42%
May 26	-57.18%
May 26	-56.49%
May 26	-53.61%
May 26	-51.72%
Apr 26	-52.54%
Apr 26	-53.61%
Apr 26	-56.6%
Apr 26	-56.12%
Mar 26	-58.1%
Mar 26	-55.18%
Mar 26	-57.09%
Mar 26	-33.28%
Feb 26	-34.61%
Feb 26	-33.86%
Feb 26	-31.93%
Feb 26	-33%
Jan 26	-31.16%
Jan 26	-29.19%
Jan 26	-30.44%
Jan 26	-30.55%
Jan 26	-32.86%
Dec 25	-31.67%
Dec 25	-31.29%
Dec 25	-32.59%
Dec 25	-31.54%
Nov 25	-34.46%
Nov 25	-34.31%
Nov 25	-29.63%
Nov 25	-35.97%
Oct 25	-35.82%
Oct 25	-32.75%
Oct 25	-33.8%
Oct 25	-33.14%
Oct 25	-31.88%
Sep 25	-31.17%
Sep 25	-30.94%
Sep 25	-30.61%
Sep 25	-28.82%
Aug 25	-26.64%
Aug 25	-26.3%
Aug 25	-26.72%
Aug 25	-35.52%
Aug 25	-36.4%
Jul 25	-36.14%
Jul 25	-34.81%
Jul 25	-36.65%
Jul 25	-32.62%
Jun 25	-37.05%
Jun 25	-41.49%
Jun 25	-39.29%
Jun 25	-35.77%
May 25	-36.4%
May 25	-36.52%
May 25	-34.12%
May 25	-38.24%
May 25	-36.28%
Apr 25	-32.92%
Apr 25	-32.58%
Apr 25	-29.21%
Apr 25	-33.38%
Mar 25	-30.9%
Mar 25	-27.85%
Mar 25	-28.94%
Mar 25	-29.48%
Feb 25	-27.21%
Feb 25	-32.04%
Feb 25	-29.29%
Feb 25	-30.9%
Jan 25	-27.69%
Jan 25	-26.25%
Jan 25	-25.08%
Jan 25	-24.69%
Jan 25	-21.67%
Dec 24	-25.21%
Dec 24	-15.01%
Dec 24	-13.78%
Dec 24	-14.97%
Nov 24	-12.59%
Nov 24	-14.03%
Nov 24	-14.38%
Nov 24	-10.67%
Nov 24	-10.96%
Oct 24	-11.23%
Oct 24	-10.67%

Price to Sales

XBIT Price to Sales by quarter
Period	Price to Sales
Apr 24	798.45
Apr 24	815.7
Apr 24	938.46
Apr 24	832.95
Mar 24	824.83
Mar 24	760.92
Mar 24	599.6
Mar 24	649.31
Mar 24	649.31
Feb 24	654.39
Feb 24	598.59
Feb 24	596.56
Feb 24	550.9
Jan 24	426.11
Jan 24	471.77
Jan 24	507.28
Jan 24	408.87
Dec 23	405.82
Dec 23	397.71
Dec 23	471.77
Dec 23	423.07
Dec 23	403.79
Nov 23	363.21
Nov 23	386.04
Nov 23	399.73
Nov 23	64.26
Oct 23	61.49
Oct 23	58.03
Oct 23	60.42
Oct 23	63.03
Sep 23	63.34
Sep 23	67.03
Sep 23	69.95
Sep 23	74.1
Sep 23	73.18
Aug 23	87.01
Aug 23	76.87
Aug 23	78.25
Aug 23	43.53
Jul 23	43.97
Jul 23	47.96
Jul 23	45.1
Jul 23	47.87
Jun 23	51.51
Jun 23	52.38
Jun 23	53.68
Jun 23	47.26
Jun 23	44.31
May 23	47.44
May 23	42.93
May 23	29.05
May 23	25.43
Apr 23	26.11
Apr 23	26.26
Apr 23	27.02
Apr 23	27.4
Mar 23	26.19
Mar 23	25.28
Mar 23	25.96
Mar 23	12.38
Mar 23	12.42
Feb 23	11.94
Feb 23	13.12
Feb 23	14.24
Feb 23	15.39
Jan 23	16.46
Jan 23	15.57
Jan 23	17.28
Jan 23	13.4
Dec 22	13.01
Dec 22	11.42
Dec 22	11.49
Dec 22	11.83
Dec 22	12.61
Nov 22	11.79
Nov 22	12.61
Nov 22	13.01
Nov 22	9.81
Oct 22	9.81
Oct 22	9.31
Oct 22	10.08
Oct 22	10.44
Sep 22	9.97
Sep 22	10.25
Sep 22	11.05
Sep 22	11.38
Sep 22	11.19
Aug 22	11.85
Aug 22	12.62
Aug 22	14.16
Aug 22	11.25
Jul 22	11.06
Jul 22	11.34
Jul 22	11.17
Jul 22	12.47
Jul 22	12.07
Jun 22	12.54
Jun 22	10.97
Jun 22	12.13
Jun 22	12.77

Price/Operating Cashflow

XBIT Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Aug 22	2.53
Jul 22	2.48
Jul 22	2.55
Jul 22	2.51
Jul 22	2.8
Jul 22	2.71
Jun 22	2.82
Jun 22	2.47
Jun 22	2.72
Jun 22	2.87
May 22	2.69
May 22	2.7
May 22	2.76
May 22	3.04
Apr 22	3.39
Apr 22	3.36
Apr 22	3.64
Apr 22	3.81
Apr 22	3.98
Mar 22	3.88
Mar 22	4.19
Mar 22	3.85
Mar 22	4.03
Feb 22	4.22
Feb 22	4.17
Feb 22	4.34
Feb 22	4.17
Jan 22	4.48
Jan 22	4.39
Jan 22	4.97
Jan 22	4.85
Dec 21	4.77
Dec 21	4.84
Dec 21	4.94
Dec 21	5
Dec 21	4.73
Nov 21	5.48
Nov 21	5.43
Nov 21	6.31
Nov 21	5.84
Oct 21	5.38
Oct 21	5.17
Oct 21	4.85
Oct 21	4.75
Oct 21	4.86
Sep 21	5.26
Sep 21	5.9
Sep 21	5.76
Sep 21	5.84
Aug 21	5.92
Aug 21	5.71
Aug 21	5.86

Price to Book

XBIT Price to Book by quarter
Period	Price to Book
Sep 26	0.52
Sep 26	0.52
Aug 26	0.54
Aug 26	0.54
Aug 26	0.55
Aug 26	0.51
Jul 26	0.5
Jul 26	0.51
Jul 26	0.51
Jul 26	0.52
Jul 26	0.52
Jun 26	0.53
Jun 26	0.52
Jun 26	0.53
Jun 26	0.54
May 26	0.55
May 26	0.55
May 26	0.56
May 26	0.53
May 26	0.55
Apr 26	0.55
Apr 26	0.53
Apr 26	0.51
Apr 26	0.51
Mar 26	0.49
Mar 26	0.52
Mar 26	0.5
Mar 26	0.43
Feb 26	0.41
Feb 26	0.42
Feb 26	0.45
Feb 26	0.43
Jan 26	0.46
Jan 26	0.49
Jan 26	0.47
Jan 26	0.47
Jan 26	0.43
Dec 25	0.45
Dec 25	0.46
Dec 25	0.44
Dec 25	0.45
Nov 25	0.41
Nov 25	0.42
Nov 25	0.48
Nov 25	0.41
Oct 25	0.41
Oct 25	0.45
Oct 25	0.44
Oct 25	0.45
Oct 25	0.47
Sep 25	0.48
Sep 25	0.48
Sep 25	0.48
Sep 25	0.51
Aug 25	0.56
Aug 25	0.56
Aug 25	0.55
Aug 25	0.51
Aug 25	0.5
Jul 25	0.5
Jul 25	0.52
Jul 25	0.49
Jul 25	0.55
Jun 25	0.49
Jun 25	0.44
Jun 25	0.46
Jun 25	0.51
May 25	0.5
May 25	0.5
May 25	0.53
May 25	0.46
May 25	0.49
Apr 25	0.46
Apr 25	0.47
Apr 25	0.52
Apr 25	0.46
Mar 25	0.49
Mar 25	0.55
Mar 25	0.53
Mar 25	0.52
Feb 25	0.56
Feb 25	0.47
Feb 25	0.52
Feb 25	0.49
Jan 25	0.55
Jan 25	0.58
Jan 25	0.61
Jan 25	0.62
Jan 25	0.7
Dec 24	0.6
Dec 24	1.01
Dec 24	1.1
Dec 24	1.02
Nov 24	1.21
Nov 24	1.08
Nov 24	1.06
Nov 24	1.17
Nov 24	1.14
Oct 24	1.11
Oct 24	1.17

No video analysis for this stock yet. Request one from our team.

News: XBIT

globenewswire.com · 15 Jun 2026

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

IND Application for V-SPINE Study Completes 30-Day FDA Review Without Clinical Hold, Clearing Path for U.S. Patient Enrollment

AI Analysis

XBiotech Inc.

Video analysis: XBIT

News: XBIT

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

Similar companies